Ibrahim Clós Mahmud, E. Lerner, Yindriana Laguna Rodriguez, P. Behar, R. Schneider
{"title":"Cognitive impairment among older adults with HIV: a systematic review protocol of cohort studies","authors":"Ibrahim Clós Mahmud, E. Lerner, Yindriana Laguna Rodriguez, P. Behar, R. Schneider","doi":"10.53886/gga.e0230005","DOIUrl":null,"url":null,"abstract":"Objectives: This review will determine whether the incidence of cognitive impairment in HIV patients aged ≥ 50 years is greater than that of their HIV-negative peers. Methods: The MEDLINE, EMBASE, LILACS, Web of Science, and Scopus databases will be searched for studies with a sample of individuals aged ≥ 50 years or a mixed population with ≥ 50% aged ≥ 50 years). It will include studies that evaluate seropositive patients compared to and an unexposed control group. Study design: Cohort studies with follow-up ≥ 24 months will be included. Three reviewers will independently screen for eligibility criteria, extract data, and assess the risk of bias in the included studies, as well as evaluate the overall quality of evidence. A narrative synthesis will be prepared according to synthesis without meta-analysis guidelines. Expected results: We expect to find correlations between older age, HIV, and cognitive impairment. Relevance: The association of geriatric syndromes and HIV is becoming an important field of study. Increased life expectancy accompanied by an active sex life is contributing to this public health problem. This protocol is reported according to the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols and is registered in PROSPERO (CRD42022321914). This study was financed in part by the CAPES foundation (financial code: 001).","PeriodicalId":52782,"journal":{"name":"Geriatrics Gerontology and Aging","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Geriatrics Gerontology and Aging","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53886/gga.e0230005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: This review will determine whether the incidence of cognitive impairment in HIV patients aged ≥ 50 years is greater than that of their HIV-negative peers. Methods: The MEDLINE, EMBASE, LILACS, Web of Science, and Scopus databases will be searched for studies with a sample of individuals aged ≥ 50 years or a mixed population with ≥ 50% aged ≥ 50 years). It will include studies that evaluate seropositive patients compared to and an unexposed control group. Study design: Cohort studies with follow-up ≥ 24 months will be included. Three reviewers will independently screen for eligibility criteria, extract data, and assess the risk of bias in the included studies, as well as evaluate the overall quality of evidence. A narrative synthesis will be prepared according to synthesis without meta-analysis guidelines. Expected results: We expect to find correlations between older age, HIV, and cognitive impairment. Relevance: The association of geriatric syndromes and HIV is becoming an important field of study. Increased life expectancy accompanied by an active sex life is contributing to this public health problem. This protocol is reported according to the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols and is registered in PROSPERO (CRD42022321914). This study was financed in part by the CAPES foundation (financial code: 001).
目的:本综述旨在确定≥50岁HIV患者的认知功能障碍发生率是否高于HIV阴性的同龄人。方法:检索MEDLINE、EMBASE、LILACS、Web of Science和Scopus数据库,检索年龄≥50岁的个体样本或年龄≥50%的混合人群(≥50岁)。它将包括评估血清阳性患者和未暴露对照组的研究。研究设计:纳入随访≥24个月的队列研究。三位审稿人将独立筛选入选标准,提取数据,评估纳入研究的偏倚风险,以及评估证据的整体质量。在没有元分析指导的情况下,根据综合来准备叙事综合。预期结果:我们期望发现年龄、HIV和认知障碍之间的相关性。相关性:老年综合征与艾滋病毒的关联正在成为一个重要的研究领域。预期寿命的延长以及性生活的活跃加剧了这一公共卫生问题。该方案根据系统评价和荟萃分析方案的首选报告项目进行报告,并在PROSPERO注册(CRD42022321914)。本研究由CAPES基金会部分资助(财务代码:001)。